Boardroom Alpha
10-Q primary document
STZ · Quarterly Report (Form 10-Q) · Filed October 7, 2025

Constellation Brands Inc10-Q exhibit

stzex103_831202510-q.htm
Document


Exhibit 10.3
Description of Compensation Arrangements for Non-Management Directors
As of July 15, 2025

The following is a description of the compensation arrangements for the non-management directors of Constellation Brands, Inc. The Company’s annual compensation program for non-management directors for their service as directors consists of a board cash retainer, a non-executive board chair cash retainer, committee chair fees, restricted stock units, an annual product allowance, and two charitable matching programs.

The board cash retainer consists of an annual retainer equal to $105,000 paid in quarterly installments. The non-executive board chair cash retainer consists of an annual retainer equal to $200,000 to be paid to the Board’s non-executive chair, if any, payable in quarterly installments. The committee chair fees consist of annual fees of $25,000 for the chair of the Audit Committee, $20,000 for the chair of the Human Resources Committee, and $20,000 for the chair of the Corporate Governance, Nominating, and Responsibility Committee, which are paid in quarterly installments.

Long-term incentive awards in the form of restricted stock units granted under the Company’s Long-Term Stock Incentive Plan are another element of non-management director compensation. As approved by the Board of Directors, each non-management director receives annually a restricted stock unit award with a grant date fair value of $185,000. (Each restricted stock unit represents a contingent right to receive one share of the Company’s Class A Common Stock.)

The value of long-term incentive awards is pro-rated for new directors. While the Board has the flexibility to determine at the time of each grant the vesting provisions for any grant, whether on-cycle or off-cycle, restricted stock units generally vest on July 10th following the date of grant. The Long-Term Stock Incentive Plan, Amended and Restated as of July 18, 2017, is filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K dated July 18, 2017 and filed July 20, 2017.

Non-management directors are reimbursed for reasonable expenses incurred in connection with their attendance at Board and Committee meetings. They also receive an annual product allowance in the form of a $10,000 cash payment and are eligible to participate in the Company’s charitable matching programs pursuant to which the Company will match donations by non-management directors up to $5,000 per calendar year to charitable organizations focused on health, education, or the arts and up to $5,000 per calendar year for contributions to the Company’s political action committee.

Members of the Board of Directors who are members of management serve without receiving any additional fees or other compensation for their service on the Board.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer